Malaysia
Search
Sign In
Change Password
Points
Sign Out
Multidisciplinary
Top Medical News
Perioperative aggressive hydration appears to be better than general hydration at preventing contrast-induced acute kidney injury (AKI) among patients with myocardial infarction with ST-segment elevation (STEMI) undergoing primary percutaneous coronary intervention (PCI), a study has found.
There appears to be substantial long-term risks and consequences of anticoagulant-related major bleeding in patients with a first unprovoked venous thromboembolism (VTE), suggests a recent study.
Indocyanine green (ICG) fluorescence imaging can help visualize intestinal blood flow better during laparoscopic surgery for strangulated bowel obstruction, a recent study has found.
Bempedoic acid may be a boon to patients with full statin intolerance, as its addition can lessen the need for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and serve as a less expensive alternative to established oral lipid-lowering medications, according to a study.
Educational intervention improves lung function, quality of life, inflammatory profile in asthmatics
An educational intervention for proper inhaled corticosteroid use helps improve lung function, quality of life, and control of inflammation among asthma patients, a recent study has found.
The large, phase III FIGARO-DKD trial strengthen the evidence on cardiovascular benefit (CV) of the nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone, in addition to its renal benefit, across a wide spectrum of patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).
The introduction of the International Classification of Disease (ICD)-10 codes for type 2 and types 3–5 myocardial infarction (MI) leads to a reduction in hospitalizations for ICD-10 codes now attributed to type 1 MI and correlates with changes in the observed characteristics and treatment patterns of these patients, according to a study.
Special Reports
The FreeStyle Libre™
flash glucose monitoring system includes a sensor which automatically measures
and continuously stores up to 8 ours of glucose readings, allowing patients to
monitor their glucose levels without the need for painful finger pricks.
Physicians play an important role in reviewing and analysing glucose data that
is available through LibreView to support patient management.
At the recent EMPIRE (Evidence on the Management Pathway In T2D with CVD Risk and REnal Impairment) Summit organised by Boehringer Ingelheim, several eminent speakers shared the latest updates on T2D management and the need for early treatment intensification to optimise patient outcomes.
At the recent Malaysian Myeloproliferative Neoplasms (MPN) Expert Forum, Professor Martin Griesshammer from the Johannes Wesling University Hospital in Germany highlighted the role of personalised clinical decision-making tools and treatment in early-stage myelofibrosis. Chaired by Dr Alan Teh, Consultant Haematologist at Subang Jaya Medical Centre, the virtual forum was organised by Novartis, in collaboration with the Malaysian Society of Haematology (MSH).
Technological advancements have improved glucose
monitoring and diabetes care, as well as empowered patients in self-care. The
introduction of continuous glucose monitoring systems (CGM), such as the
Abbott FreeStyle LibreTM, offers patients an alternative and
additional advantages to self-monitoring of blood glucose (SMBG).
DKD is the principal cause of ESRD and remains one of the most prevalent complications among patients with T2DM.Hyperglycaemia is the main factor in the development and progression of DKD; once established, it triggers multiple pathogenic processes (eg, hypertension, altered tubuloglomerular feedback, renal hypoxia, lipotoxicity, inflammation), leading to a progressive decline in GFR.
At the recent Malaysia Myeloproliferative Neoplasms (MPN) Expert Forum webinar, Associate Professor Dr Haifa Kathrin Al-Ali, Senior Consultant of Haematology and Oncology and the head of the Krukenberg Cancer Center, University Hospital of Halle (Saale), Germany, presented the case for earlier treatment of myelofibrosis (MF) and better symptom management. The webinar was organized by Novartis in collaboration with the Malaysian Society of Haematology (MSH), and chaired by Dr Chew Lee Ping, Consultant Haematologist from Hospital Umum Sarawak.
During the EMPIRE Summit sponsored by Boehringer Ingelheim, two distinguished speakers shared their insights into the evolving treatment landscape of DKD. Topics discussed include the role of SGLT-2iin fulfilling the unmet needs in DKD management and how evidence of their cardio renal-protective effects have altered clinical practice guidelines globally.
Conference Reports
The large, phase III FIGARO-DKD trial strengthen the evidence on cardiovascular benefit (CV) of the nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone, in addition to its renal benefit, across a wide spectrum of patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).
Beyond 1 year, the humanized monoclonal antibody mepolizumab maintained real-world efficacy and safety in patients with severe eosinophilic asthma in the REALITI-A cohort study, reports an expert at ERS 2021.
Adding cyclophosphamide to glucocorticoid treatment in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) was associated with a numerically increased risk of mortality, according to results of the phase III EXAFIP trial.
What used to be a place that holds a perception of relative safety and minimal health risk to its occupants, the office now appears to be a place that is inching its way towards the other side of the respiratory health spectrum, with office-related occupational asthma on the rise, according to findings from a UK cross-sectional study presented at ERS 2021.
Treatment with MV130, a sublingual bacterial immunotherapy, reduces the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a recent study presented at ERS 2021.
Home-based inspiratory muscle training (IMT) – incorporated into COVID-19 rehabilitation programme – speeds up the recovery of patients in a UK study presented at ERS 2021.
Children with asthma are less likely to respond to inhaled corticosteroid (ICS) if they also happen to obese or overweight, suggests a study presented at ERS 2021.
Multimedia
